Form 4 for RMD ResMed|
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001127602-23-028005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-20 | 2023-11-16 | RMD | Drexler Karen | Dir | A - Grant | $0.00 | +884 | 8,871 | +11% | $0 |
| D | 2023-11-20 | 2023-11-16 | RMD | Drexler Karen | Dir | A - Grant | $148.90 | +2,575 | 2,575 | New | +$383.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-11-16 | A | A | 884 | $0.00 | 8,871 | D | — | — | (F1) Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date. |
| 2 | Derivative | ResMed Common Stock Options | 2023-11-16 | A | A | 2,575 | $148.90 | 2,575 | D | $148.90 · 2024-11-11 to 2030-11-16 | 2,575 ResMed Common Stock | (F2) Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. |